Could targeting oxtyocin help treat opioid addiction?

April 5, 2017, Wiley
Pills. Credit: Public Domain

A new review of published research indicates that the oxytocin system—a key player in social reward and stress regulation—is profoundly affected by opioid use. Therefore, it may be an important target for developing medications to treat opioid addiction and to prevent relapse.

"Social withdrawal is one of the key factors that can predispose people to heroin but is also a consequence of drug use," said Dr. Alexis Bailey, senior author of the British Journal of Pharmacology review.

"Given the benefits that social support programs like Alcoholics Anonymous and Narcotics Anonymous have in keeping addicts abstinent, current findings in the review suggest the use of the prosocial hormone oxytocin as a novel effective 'psycho-biological therapy' for the prevention of relapse to drug-use in drug dependent individuals. Therefore clinical studies assessing the efficacy of oxytocin-based pharmacotherapies in addiction are warranted."

Explore further: Opioid users treated in drug detention centers more likely to relapse

More information: British Journal of Pharmacology (2017). DOI: 10.1111/bph.13757

Related Stories

Opioid users treated in drug detention centers more likely to relapse

December 8, 2016
Individuals who are dependent on opioids are more likely to relapse after treatment in a compulsory drug detention center versus a voluntary drug treatment center that provides methadone therapy, say the Yale authors of a ...

Use of psychosocial treatments in conjunction with medication for opioid addiction—recommended, but research is sparse

January 26, 2016
Psychosocial interventions, used together with effective medications, are a key part of recommended treatment for opioid addiction. But while research generally supports the effectiveness of psychosocial treatments, there ...

Treat patients with addiction during, after hospitalization, researchers say

June 30, 2014
The results of a new study demonstrate that starting hospitalized patients who have an opioid (heroin) addiction on buprenorphine treatment in the hospital and seamlessly connecting them with an outpatient office based treatment ...

Can 'love hormone' oxytocin protect against addiction?

March 19, 2014
(Medical Xpress)—Researchers at the University of Adelaide say addictive behaviour such as drug and alcohol abuse could be associated with poor development of the so-called "love hormone" system in our bodies during early ...

Commercial weight-loss drug could help treat opioid addiction

February 8, 2017
Scientists are working to come up with new therapies to curb America's opioid epidemic and aid hospitals, doctors and public health officials in this fight. Now one team reports in the journal ACS Chemical Neuroscience that ...

Opportunities for addiction care and HIV prevention in Russia

January 23, 2017
Opioid agonist therapy using methadone is regarded as one of the most effective treatments for opioid use disorders as well as helping to reduce HIV risks. Such therapy, however, is not yet available in Russia.

Recommended for you

US approves first generic competitor to Mylan's EpiPen

August 16, 2018
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring prices for the original version owned by Mylan stoked controversy.

Study: What patients really think about opioid vs non-opioid medications for chronic pain

August 14, 2018
Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone ...

Doctors nudged by overdose letter prescribe fewer opioids

August 9, 2018
In a novel experiment, doctors got a letter from the medical examiner's office telling them of their patient's fatal overdose. The response: They started prescribing fewer opioids.

Benzodiazepine and related drug prescriptions have increased among young people in Sweden

August 7, 2018
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 ...

Unwise opioids for wisdom teeth: Study shows link to long-term use in teens and young adults

August 7, 2018
Getting wisdom teeth removed may be a rite of passage for many teens and young adults, but the opioid painkiller prescriptions that many of them receive could set them on a path to long-term opioid use, a new study finds.

Behavioral nudges lead to striking drop in prescriptions of potent antipsychotic

August 1, 2018
A study led by Columbia University's Mailman School of Public Health has found that letters targeting high prescribers of Seroquel (quetiapine), an antipsychotic with potentially harmful side effects in the elderly, significantly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.